• LAST PRICE
    20.5400
  • TODAY'S CHANGE (%)
    Trending Up0.2800 (1.3820%)
  • Bid / Lots
    19.7500/ 1
  • Ask / Lots
    21.4700/ 1
  • Open / Previous Close
    20.2700 / 20.2600
  • Day Range
    Low 20.2600
    High 21.6000
  • 52 Week Range
    Low 13.3100
    High 28.6701
  • Volume
    536,420
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 20.26
TimeVolumeBCYC
09:32 ET121821.055
09:33 ET90020.2736
09:35 ET706020.3
09:37 ET41220.73
09:39 ET20020.52
09:42 ET98220.6
09:44 ET154820.57
09:46 ET10020.58
09:48 ET10020.6481
09:50 ET21520.66
09:53 ET54220.68
09:55 ET47520.7
10:00 ET40020.685
10:02 ET10020.68
10:04 ET10020.695
10:06 ET42620.54
10:08 ET20020.61
10:18 ET20020.605
10:20 ET110020.6
10:22 ET92020.6
10:26 ET10020.58
10:27 ET46320.58
10:31 ET40020.55
10:38 ET226520.59
10:40 ET60120.62
10:42 ET10020.62
10:45 ET223420.76
10:47 ET10020.79
10:49 ET24520.72
10:54 ET100020.69
11:00 ET88020.625
11:02 ET30020.6918
11:03 ET10020.615
11:07 ET40020.67
11:12 ET10020.68
11:14 ET80220.68
11:16 ET310420.735
11:18 ET20020.75
11:21 ET10020.7
11:23 ET421820.64
11:25 ET30020.67
11:27 ET30020.67
11:32 ET30020.62
11:34 ET30020.67
11:36 ET40020.615
11:39 ET10020.68
11:48 ET297220.635
11:56 ET40020.635
11:57 ET30020.635
11:59 ET1451920.64
12:01 ET760120.61
12:03 ET95820.65
12:06 ET52620.61
12:10 ET132020.61
12:17 ET104820.575
12:24 ET151220.575
12:32 ET52020.54
12:33 ET20020.58
12:35 ET73220.5899
12:37 ET11520.59
12:39 ET30020.5885
12:42 ET20020.555
12:44 ET1825020.6
12:46 ET80020.59
12:48 ET40020.615
12:50 ET324220.58
12:51 ET712520.605
12:53 ET40020.61
12:57 ET122220.55
01:08 ET140020.59
01:09 ET233620.6
01:11 ET50020.615
01:13 ET20020.615
01:15 ET30020.595
01:18 ET420020.63
01:20 ET1094520.64
01:22 ET630020.62
01:24 ET30020.66
01:26 ET10020.68
01:27 ET67220.67
01:29 ET128520.6
01:36 ET20020.63
01:38 ET90020.63
01:40 ET40020.63
01:42 ET160020.58
01:45 ET20020.6
01:47 ET30020.615
01:49 ET83920.6
01:51 ET110020.58
01:54 ET20020.6
01:58 ET85020.6164
02:00 ET405820.58
02:02 ET1048720.605
02:03 ET60020.595
02:05 ET20020.62
02:09 ET310920.615
02:12 ET204220.615
02:14 ET90020.625
02:16 ET122720.59
02:18 ET10020.61
02:20 ET10020.61
02:23 ET10020.61
02:25 ET10020.595
02:27 ET20020.6
02:32 ET20020.57
02:34 ET30020.6
02:36 ET120020.59
02:38 ET20020.6
02:39 ET90020.605
02:41 ET130020.6
02:43 ET30020.59
02:45 ET172820.51
02:48 ET41920.58
02:50 ET20020.565
02:52 ET100020.6
02:56 ET92020.55
02:59 ET121120.51
03:01 ET140020.545
03:03 ET93520.5
03:06 ET140020.49
03:08 ET10020.55
03:10 ET70020.505
03:12 ET37720.47
03:14 ET20020.54
03:15 ET10020.5
03:17 ET10020.52
03:21 ET85720.47
03:30 ET65020.46
03:35 ET30020.44
03:37 ET146620.45
03:39 ET10020.42
03:42 ET157520.5
03:44 ET81920.55
03:46 ET274320.595
03:48 ET87820.55
03:50 ET350020.6
03:51 ET240020.59
03:53 ET352020.605
03:55 ET120020.61
03:57 ET280020.6
04:00 ET2194420.54
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBCYC
Bicycle Therapeutics PLC
1.4B
-6.3x
---
United StatesNTLA
Intellia Therapeutics Inc
1.4B
-2.6x
---
United StatesSYRE
Spyre Therapeutics Inc
1.4B
-3.7x
---
United StatesPRAX
Praxis Precision Medicines Inc
1.4B
-7.2x
---
United StatesDAWN
Day One Biopharmaceuticals Inc
1.3B
-13.4x
---
United StatesSNDX
Syndax Pharmaceuticals Inc
1.3B
-4.4x
---
As of 2024-11-22

Company Information

Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. The Company is evaluating BT8009, a Bicycle Toxin Conjugate (BTC) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC targeting EphA2, a historically undruggable target, and BT7480, a Bicycle Tumor-Targeted Immune Cell Agonist (Bicycle TICA) targeting Nectin-4 and agonizing CD137, in Company-sponsored clinical trials. Additionally, the Company is developing Bicycle Radio Conjugates (BRC) for radiopharmaceutical use and, through various partnerships, is exploring the use of Bicycle technology to develop therapies for diseases beyond oncology. Its product candidates also include BT1718 and BT7455.

Contact Information

Headquarters
Blocks A & B, Portway Building, Granta PCAMBRIDGE, United Kingdom CB21 6GS
Phone
122-326-1503
Fax
---

Executives

Non-Executive Chairman of the Board
Pierre Legault
Chief Executive Officer, Executive Director
Kevin Lee
Chief Financial Officer, Principal Financial Officer
Alethia Young
Chief Operating Officer
Alistair Milnes
Chief Technology Officer
Michael Skynner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4B
Revenue (TTM)
$36.9M
Shares Outstanding
69.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.88
EPS
$-3.28
Book Value
$8.74
P/E Ratio
-6.3x
Price/Sales (TTM)
37.9
Price/Cash Flow (TTM)
---
Operating Margin
-534.98%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.